Industry News
Compumedics revises revenue figure, shares drop
Sleep device developer Compumedics has flagged a 10 per cent reduction in its forecast sales for the year, triggering a share price slide. [ + ]
Autogen's 'beacon' gene wins patent protection
A gene implicated in conditions including obesity, diabetes and energy imbalance has gained Australian patent protection four years after its initial discovery. [ + ]
Bioinformatics course kicks off in Qld
Australia's most ambitious attempt at bringing computer scientists and bioscientists together for bioinformatics training was launched this week in Queensland. [ + ]
Skin cancer prevention treatment developed at Uni of SA
Scientists at the University of South Australia's Centre for Pharmaceutical Research have developed a topical treatment that could be used to prevent skin cancers from developing in susceptible people. [ + ]
Which genes make the best baked dinner?
A project at the South Australian Research and Development Institute (SARDI) is focusing on the qualities that make lamb tender and tasty. [ + ]
Going for funding? Get a cash parachute, says Alchemia CEO
Biotech companies in the midst of new funding rounds should build an extra cushion of cash into their requests, warns Alchemia CEO Tracie Ramsdale. [ + ]
Prima meets cancer milestones
Drug development company Prima Biomed has told the market its first year research programs into cancer immunotherapy and anti-inflammatory treatments had met or exceeded their milestones. [ + ]
Starpharma finalises US nanotech set-up
Australia's place in the futuristic world of nanotechnology has been further cemented with the set up of Dendrimer Nanotechnologies (DNT) now complete. [ + ]
Strong US sales for Genetic Solutions
Two ex-CSIRO scientists who have spent four years quietly commercialising Australian expertise in livestock DNA testing are in the midst of a US sales boom. [ + ]
Peptech earns TNF patent protection in US
Sydney-based biotech Peptech has gained United States patent protection for its tumour necrotising factor (TNF) antibodies, priming the company for its next growth phase. [ + ]
Australia must wake up to the power of light
"It's time for Australian industry to wake up to the power of light," says Sir Peter Williams, President of the UK Institute for Physics.
[ + ]Researchers welcome xenotransplantation guidelines
Australian researchers have welcomed the National Health and Medical Research Council's draft guidelines on xenotransplantation, released yesterday. [ + ]
EQiTX sets itself up for biotechnology
A Western Australian oil and metal exploration company has gathered some of the top names in Australian science as it moves towards rebirth as a biotech. [ + ]
Victoria to host synchrotron conference in 2005
Victoria has beaten a host of other nations to win the right to stage an international synchrotron conference in 2005. [ + ]
BioProspect's Japanese Qcide deal
Natural insecticide developer BioProspect has reached a second deal over rights to test its new product. [ + ]
